Choline chloride in schizophrenia
- 1 December 1979
- journal article
- clinical trial
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 136 (12) , 1581-1584
- https://doi.org/10.1176/ajp.136.12.1581
Abstract
The authors investigated the possibility that choline chloride might reduce schizophrenic symptoms by increasing central cholinergic activity. In a single blind crossover study, up to 20 g/day of choline chloride had no significant effect on clinical ratings of nine schizophrenic patients. However, there was some evidence that choline significantly increased symptoms of depression.Keywords
This publication has 26 references indexed in Scilit:
- Cholinergic inhibition of methylphenidate-induced stereotypy: OxotremorinePsychopharmacology, 1978
- Physostigmine in ManiaArchives of General Psychiatry, 1978
- Physostigmine: Effects on cognition and affect in normal subjectsPsychopharmacology, 1976
- Effects of antagonists upon locomotor stimulation induced by injection of dopamine and noradrenaline into the nucleus accumbens of nialamide-pretreated ratsPsychopharmacology, 1975
- Antischizophrenic Drugs and Brain Cholinergic ReceptorsArchives of General Psychiatry, 1974
- The effects of physostigmine in phenothiazine resistant chronic schizophrenic patients: Preliminary observationsComprehensive Psychiatry, 1973
- Parasympathetic Suppression of Manic Symptoms by PhysostigmineArchives of General Psychiatry, 1973
- Cholinergic antagonism of methylphenidate-induced stereotyped behaviorPsychopharmacology, 1972
- Diagnostic Criteria for Use in Psychiatric ResearchArchives of General Psychiatry, 1972
- Comparative Lucid Intervals After Amobarbital, CO2, and Arecoline in the Chronic SchizophrenicArchives of Neurology & Psychiatry, 1957